You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Reprofiled Drug

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Amoebic Dysentery, Giardiasis Trial in Dhaka, Rajshahi 6000 (Auranofin, Placebo)

Completed
  • Amoebic Dysentery
  • Giardiasis
  • Dhaka, Bangladesh
  • +1 more
May 26, 2022

Drug-drug Interaction Study Trial in Hyderabad (SPRYCEL® (dasatinib) 100 mg Film-Coated Tablets in combination with Omeprazole

Completed
  • Drug-drug Interaction Study
  • SPRYCEL® (dasatinib) 100 mg Film-Coated Tablets in combination with Omeprazole Delayed-Release Capsules USP, 40 mg
  • Hyderabad, India
    QPS Bioserve India Pvt Limited
Nov 20, 2023

Nonalcoholic Steatohepatitis, Genetic Risk Factor Trial (ALN-PNP Dose Level 1, ALN-PNP Dose Level 2, ALN-PNP Dose Level 3)

Not yet recruiting
  • Nonalcoholic Steatohepatitis
  • Genetic Risk Factor
  • ALN-PNP Dose Level 1
  • +3 more
  • (no location specified)
Sep 5, 2023

Primary Open Angle Glaucoma of Both Eyes Trial in Kazan (Dorzol 20 mg/ml, Trusopt 20 mg/ml)

Completed
  • Primary Open Angle Glaucoma of Both Eyes
  • Dorzol 20 mg/ml
  • Trusopt 20 mg/ml
  • Kazan, Russian Federation
    State autonomous healthcare institution 'Republican Clinical Oph
Jul 26, 2023

Healthy Volunteers Trial (REGN7544, Matching Placebo)

Not yet recruiting
  • Healthy Volunteers
  • (no location specified)
Jul 24, 2023

Healthy Trial in Seoul (Test Drug(JW0302) or Reference Drug(C2206))

Not yet recruiting
  • Healthy
  • Test Drug(JW0302) or Reference Drug(C2206)
  • Seoul, Korea, Republic of
    Clinical Trial Center, Seoul National University Hospital
Mar 14, 2023

Primary Open Angle Glaucoma of Both Eyes Trial in Kazan (Dorzotimol eye drops, 20 mg/mL + 5 mg/mL, Cosopt eye drops, 20 mg/mL +

Completed
  • Primary Open Angle Glaucoma of Both Eyes
  • Dorzotimol eye drops, 20 mg/mL + 5 mg/mL
  • Cosopt eye drops, 20 mg/mL + 5 mg/mL
  • Kazan, Russian Federation
    Republican Clinical Ophthalmological Hospital of the Ministry of
Jul 26, 2023

Follicular Lymphoma (FL) Trial in Westbury (Odronextamab, Rituximab, Cyclophosphamide)

Recruiting
  • Follicular Lymphoma (FL)
  • Westbury, New York
    Clinical Research Alliance Inc
Oct 13, 2023

Heart Failure Congenital Trial in Beijing (Captopril Tablets, Metoprolol Oral Tablet, Spironolactone Tablets)

Recruiting
  • Heart Failure Congenital
  • Captopril Tablets
  • +4 more
  • Beijing, Beijing, China
    Fuwai hospital
Sep 9, 2023

NSCLC Trial in Rockville (Crizotinib - Usual, Crizotinib - Study)

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • Crizotinib - Usual
  • Crizotinib - Study
  • Rockville, Maryland
    Medicine Invention Design, Inc. - IORG0007849
Oct 5, 2023

Healthy Trial in Qingdao (VDJ001, Placebo)

Completed
  • Healthy
  • Qingdao, Shandong, China
    the Affliated Hospital of Qingdao University
Aug 30, 2023

Healthy Volunteers Trial (REGN13335, Matching Placebo)

Not yet recruiting
  • Healthy Volunteers
  • (no location specified)
Nov 13, 2023

Congenital Mitral Insufficiency Trial in Beijing (Captopril Tablets, Metoprolol Oral Tablet, Spironolactone Tablets)

Recruiting
  • Congenital Mitral Insufficiency
  • Captopril Tablets
  • +4 more
  • Beijing, Beijing, China
    Fuwai hospital
Sep 13, 2023

Congenital Mitral Insufficiency Trial in Beijing (Captopril Tablets, Metoprolol Oral Tablet, Spironolactone Tablets)

Recruiting
  • Congenital Mitral Insufficiency
  • Captopril Tablets
  • +4 more
  • Beijing, Beijing, China
    Fuwai hospital
Sep 9, 2023

COPD Exacerbation, COPD Trial in Uppsala (EP395 (Part A and B), Verapamil (Part A), Midazolam (Part B))

Recruiting
  • Chronic Obstructive Pulmonary Disease Exacerbation
  • COPD
  • EP395 (Part A and B)
  • +3 more
  • Uppsala, Sweden
    Clinical Trial Consultants AB
Nov 1, 2023

NSCLC Trial in Rockville (Crizotinib - Usual, Crizotinib - Study)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • Crizotinib - Usual
  • Crizotinib - Study
  • Rockville, Maryland
    Medicine Invention Design, Inc. - IORG0007849
Aug 15, 2023

Smoldering Multiple Myeloma (SMM) Trial (Linvoseltamab)

Not yet recruiting
  • Smoldering Multiple Myeloma (SMM)
  • (no location specified)
Jul 13, 2023

Drug Abuse Trial in Hong Kong (AA group, Control group)

Recruiting
  • Drug Abuse
  • AA group
  • Control group
  • Hong Kong, Hong Kong,China, Hong Kong
    Katherine Lam
May 25, 2023

Advanced Solid Tumor, Metastatic Solid Tumor Trial in Canton (TPX-0005, Metformin Hydrochloride, Digoxin)

Recruiting
  • Advanced Solid Tumor
  • Metastatic Solid Tumor
  • Canton, Ohio
    Gabrail Cancer Research Center
Apr 25, 2023

Ovarian Cancer Trial in Turku (KAND145, Placebo)

Not yet recruiting
  • Ovarian Cancer
  • Turku, Finland
    Clinical Research Services Turku - CRST Oy
Sep 26, 2023

Trypanosomiasis, African Trial in Kuala Lumpur (Acoziborole, Midazolam, Dextromethorphan)

Completed
  • Trypanosomiasis, African
  • Kuala Lumpur, Malaysia
    Clinical Research Center (CRC) Ampang Hospital
Jul 7, 2023

Pattern of Acute Antipsychotic Drug- Toxicity in Children

Not yet recruiting
  • Antipsychotic Drug- Toxicity
    • (no location specified)
    Nov 6, 2023

    Type 2 Diabetes Trial in Beijing (HSK7653, Metformin)

    Completed
    • Type 2 Diabetes Mellitus
    • Beijing, Beijing, China
      Peking University Third Hospital
    Oct 10, 2023

    Liver Cirrhosis Trial (Caffeine, Warfarin sodium, Omeprazole)

    Not yet recruiting
    • Liver Cirrhosis
    • (no location specified)
    Feb 14, 2023

    Follicular Lymphoma (FL) Trial in Noblesville (Odronextamab, Rituximab, Cyclophosphamide)

    Recruiting
    • Follicular Lymphoma (FL)
    • Noblesville, Indiana
      Investigative Clinical Research of Indiana
    Oct 18, 2023